Total planned funding: $202,007,142
Allocations
Countries/Regions
India | $202,007,142 |
Organizational Types
Unknown | $86,634,635 |
NGO | $60,660,170 |
Own Agency | $29,497,645 |
University | $15,182,112 |
Multi-lateral Agency | $3,516,808 |
Private Contractor | $3,348,272 |
FBO | $1,600,000 |
Host Country Government Agency | $940,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $73,784,789 |
Prevention | $50,998,790 |
Care | $27,817,797 |
Management and Operations | $22,142,324 |
Testing | $11,967,284 |
Treatment | $10,868,366 |
Budget Codes
OHSS: Health Systems Strengthening | $42,257,190 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,938,406 |
HVSI: Strategic Information | $25,439,786 |
HVMS: Management and Operations | $22,142,324 |
HBHC: Care: Adult Care and Support | $18,001,385 |
HVCT: Testing: HIV Testing and Counseling | $11,967,284 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,260,149 |
HTXS: Treatment: Adult Treatment | $10,384,871 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,265,110 |
HLAB: Laboratory Infrastructure | $6,087,813 |
HKID: Care: Orphans and Vulnerable Children | $5,276,767 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,225,472 |
HVTB: Care: TB/HIV | $3,786,305 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $753,340 |
PDTX: Treatment: Pediatric Treatment | $460,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$86,010,146
Countries/Regions
FHI 360:
$20,879,182
Countries/Regions
USG Aggregated Agencies:
$18,929,578
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions